Jiangsu Nanfang Medical Co., Ltd. cancelled the acquisition of 65% in Anhui Huize New Material Technology Co., Ltd. from Shu Zhengjun.
September 08, 2020
Share
Jiangsu Nanfang Medical Co., Ltd. (SHSE:603880) agreed to acquire 65% in Anhui Huize New Material Technology Co., Ltd. from Shu Zhengjun for CNY 0.21 million on September 8, 2019. Post completion, Shu Zhengjun will hold 35% in Anhui Huize New Material Technology Co., Ltd. For the year ended December 31, 2018, Anhui Huize New Material Technology Co., Ltd. reported total assets of CNY 6.4 million, net assets of CNY 1 million, nil revenues and net loss of CNY 0.47 million. The Board of directors of Jiangsu Nanfang Medical Co., Ltd. approved the deal. The deal does not require approval from shareholders.
Jiangsu Nanfang Medical Co., Ltd. (SHSE:603880) cancelled the acquisition of 65% in Anhui Huize New Material Technology Co., Ltd. from Shu Zhengjun on September 8, 2020.
Jiangsu Nanfang Medical Co., Ltd. is a China-based company which is mainly engaged in manufacture and sales of medical dressings and pharmaceutical products. The Company is mainly engaged in research and development, manufactures and sales of transdermal products, medical tape and bandages, sports protection products, first-aid kits, nursing products and others. The Companyâs main products include Band-Aid, patches, medical tapes, plaster dressings, sports protection products, first-aid kits, care products and other products. The Companyâs brands include MIAO-SHOU, Oushun and others.
JIANGSU NANFANG MEDICAL CO., LTD. 
